Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A kind of pharmaceutical composition containing luteolin and its application

A technology of luteolin and composition, which is applied in the field of medicine to achieve the effects of reducing production and packaging costs, reducing dosage, and increasing treatment compliance

Inactive Publication Date: 2015-11-18
郝敬卫
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there is no report about the combined application of olmesartan medoxomil and luteolin in the prior art, especially no antihypertensive report after the combined application of the two

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1 Study on the curative effect of combined use of olmesartan medoxomil and luteolin on hypertensive rats

[0021] A total of 40 8-week-old spontaneous hereditary hypertensive rats (SHR) were purchased from Shanghai Slack Experimental Animal Co., Ltd. According to body weight, they were randomly divided into model control group, luteolin group, olmesartan group and combination drug group, totally 4 groups, 10 rats in each group. Luteolin and olmesartan medoxomil were formulated with an appropriate amount of purified water to prepare a medicinal solution, and the rats in each group were intragastrically administered for 10 weeks, and the doses were as follows:

[0022] Model control group: the same volume of purified water;

[0023] Luteolin group: 10mg / (kg?d) luteolin;

[0024] Olmesartan group: 1mg / (kg?d) olmesartan medoxomil;

[0025] Combined medication group: 10mg / (kg?d) luteolin + 1mg / (kg?d) olmesartan medoxomil.

[0026] Tail artery systolic blood pres...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition containing cyanidenon and use thereof. The active component of the pharmaceutical composition is prepared from olmesartan medoxomil and cyanidenon, and the weight ratio of the olmesartan medoxomil to the cyanidenon is preferably 1:(2-20). The blood pressure can be slowly and stably reduced by adopting low-dosage cyanidenon combined with olmesartan medoxomil, so that protection of structure and function of the hypertensive target organ is facilitated, and the occurrence rate of a cardiovascular event is further reduced.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a pharmaceutical composition, in particular to a pharmaceutical composition containing a small dose of luteolin and its application. Background technique [0002] Hypertension is the most common cardiovascular disease and has become a major public health problem worldwide. According to statistics from the national health department, by the end of 2006, the number of hypertensive patients in my country had reached 160 million, and more than 3 million new patients were added every year. [0003] Hypertension is a syndrome with very complicated etiology and pathogenesis. Once diagnosed, it requires life-long medication. At present, domestic and foreign medical circles generally tend to use two antihypertensive drugs with different mechanisms of action in combination. According to the sixth report of the National Committee on the Prevention, Detection, Evaluation, and Treatment of Hy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4178A61P9/12A61K31/352
Inventor 陈金杰
Owner 郝敬卫
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com